Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1070 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2023-01-31 (nasdaq.com)
Fmr Cuts Stake in Charles River Laboratories Intl. (CRL)
Fintel reports that Fmr has filed a 13G/A form with the SEC disclosing ownership of 0.56MM shares of Charles River Laboratories Intl. Inc (CRL). This represents 1.095% of the company.
Read more
(biospace.com)
Layoff Tracker: Idorsia Pharmaceuticals Could Cut 270 Employees Globally
2023 was a tough year for the biopharma industry, with several companies downsizing and restructuring their workforces to stay afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and life sciences industry in the latter part of 2023 and have continued their upswing into 2024. Will the job market follow suit?
Read more